Bender Ignacio, Rachel A.
Goldman, Jason D.
Magaret, Amalia S.
Selke, Stacy
Huang, Meei-Li
Gantt, Soren
Johnston, Christine
Phipps, Warren T.
Schiffer, Joshua T.
Zuckerman, Richard A.
McClelland, R. Scott
Celum, Connie
Corey, Larry
Wald, Anna
Casper, Corey
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (T32-AI-007140, K23-AI-054162, K24-AI-071113, P01-AI-030731, R37-AI-042528)
National Cancer Institute (T32-CA-080416, K24-AI-071113, P30-CA-015704, R01-CA-086795)
GlaxoSmithKline (Valacyclovir study)
Center for AIDS Research, University of Washington (P30-AI-027757, P30-AI-027757)
Fred Hutchinson Cancer Research Center (Early Detection Initiative)
AIDS Clinical Trials Group (U01-AI-038858)
Article History
Received: 8 October 2015
Accepted: 28 December 2015
First Online: 10 February 2016